Hereditary Cancer Syndromes

Robin Wilson¹, Nicholas Bartell^{1

2}, Danielle Marino^{1

2}

Affiliations

¹ Department of Gastroenterology, University of Rochester Medical Center, Rochester, New York, USA .
² Wilmot Cancer Institute Hereditary Cancer Screening and Risk Reduction Program, Rochester, New York, USA.

Robin Wilson et al. Am J Gastroenterol. 2024.

. 2024 Oct 25;120(6):1171-1174.

doi: 10.14309/ajg.0000000000003162.

Robin Wilson¹, Nicholas Bartell^{1

2}, Danielle Marino^{1

2}

¹ Department of Gastroenterology, University of Rochester Medical Center, Rochester, New York, USA .
² Wilmot Cancer Institute Hereditary Cancer Screening and Risk Reduction Program, Rochester, New York, USA.

No abstract available

References

1. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96(4):261–8.
1. Syngal S, Brand RE, Church JM, et al.; American College of Gastroenterology ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110(2):223–63.
1. Win AK, Jenkins MA, Dowty JG, et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomark Prev 2017;26(3):404–12.
1. Tiwari AK, Roy HK, Lynch HT. Lynch syndrome in the 21st century: Clinical perspectives. QJM 2016;109(3):151–8.
1. National Comprehensive Cancer Network. Genetic/familial high-risk assessment: Colorectal (version 2.2023) ( https://www.nccn.org/professionals/physicians_gls/pdf/genetics_colon.pdf ) (2023). Accessed October 2, 2024.